Quinidine sulphate
Quinidine sulphate, an inorganic sulphate drug compound
HSN 2833 29 30 (Quinidine sulphate) is subject to Central Board of Indirect Taxes and Customs (CBIC) documentation requirements at the bill-of-entry stage, including mandatory Drug Import Licence, Registration Certificate, Certificate of Analysis, and Batch Release Certificate uploaded in e-Sanchit. CBIC Circular 23/2023-Cus dated 30-09-2023 additionally mandates Chapter 28 qualifiers in the import declaration with effect from 15 October 2023.
- Import licence for drugs from CBIC
- Registration certificate from CBIC
- Certificate of analysis from CBIC
- 1Upload all five mandatory drug-import documents in e-Sanchit before filing the bill of entry: Certificate of Analysis (document code 0010dc), Batch Release Certificate (document code 0030dc), Label of Consignment (document code 0110dc), Registration Certificate for drugs (document code 101dc1), and Import Licence for drugs (document code 9111dc). The proper officer will verify these uploads before granting out-of-charge.e-Sanchit mandatory document codes 0010dc, 0030dc, 0110dc, 101dc1, 9111dc — CBIC CCR for CTH 2833 29 30
- 2Ensure the import declaration includes the mandatory additional qualifiers for Chapter 28 commodities as stipulated in paragraphs 4.1 and 4.2 of CBIC Circular 23/2023-Cus. These qualifiers are compulsory with effect from 15 October 2023; declarations lacking them are liable to rejection at the bill-of-entry stage.CBIC Circular 23/2023-Cus dated 30-09-2023, paragraphs 4.1 and 4.2
The most common error on this tariff line is filing the bill of entry with the drug-import documents in hand but omitting the Chapter 28 mandatory qualifiers required under CBIC Circular 23/2023-Cus. A declaration that satisfies all five e-Sanchit document codes yet lacks the Chapter 28 qualifiers in paragraphs 4.1 and 4.2 remains non-compliant and will be rejected, resulting in detention and demurrage until a corrected declaration is accepted.